- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Mexico Moves to Legalize Marijuana–Will Canada Benefit?
Now that Mexico is on the path to cannabis legalization for medical and scientific purposes, what potential is there for Canadian companies to explore the market?
The cannabis legalization movement is expanding with Mexico now set to adopt a law making it legal for medical and scientific purposes.
On April 28, the Lower House of Congress approved a previously voted bill, according to the Yucatan Times, and will now go to the hands of Mexican president Enrique Peña Nieto for approval. According to Reuters, he is expected to sign it into law.
Despite the excitement surround the news, experts have said to lower expectations when it comes to drug trafficking in Mexico since the bill only refers to medical and scientific use.
“It won’t change anything,” Raúl Benítez Manau, an expert on security affairs at the National Autonomous University of Mexico told the AFP. “Narcotrafficking is going to stay the same.”
Mexican officials will now have to begin drafting specific instructions for medical companies to follow as they begin using cannabis in their research.
Interest from Canada
Thanks to this announcement, Aaron Salz, an advisor for Canadian companies in the cannabis sector with Stoic Advisory, said in an interview with the Investing News Network it’s now likely for some types of partnerships to develop.
“I think you will definitely see interest in Canadian companies in participating in the Mexican market,” he said. “You will definitely see interest in companies right away in exporting to the Mexican market and to aiding those companies there in getting things set up.”
However, Salz also said he doesn’t think any companies will be rushing to set up shop in Mexico, due to an uncertainty in what the licensing process may look like there.
“You’ll certainly see partnerships, you’ll see information sharing. I would almost be certain that the regulators will communicate with each other if they haven’t already,” Salz added.
Salz told the Investing News Network one of the most exciting things in the cannabis sector right now is that Canadian companies can be part of the export process for medical purposes in countries like Brazil, Australia, and Germany.
As of yet, no information regarding potential developing partnerships or interest related to Mexico’s cannabis legalization has been released, but it is more likely than those deals will begin taking some form in the coming months once the law is set in place.
Investor Takeaway
The news of legalization from a country that has a positive business relationship with Canada should excited investors in the market. The test is now to wait and see which company will launch themselves into the Mexican market.
Don’t forget to follow @INN_LifeScience for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.